Health Condition 1: J00-J99- Diseases of the respiratory system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants with mild to moderate symptoms of allergic rhinitis. Willingness to participate and provide regular feedback. No history of nasal surgery or other nasal interventions in the past six months.
Exclusion criteria
Exclusion criteria: Participants with severe nasal polyps or chronic sinusitis. History of hypersensitivity to Budesonide, Vitamin D, or Vitamin E. Pregnant or lactating women. Individuals unable to adhere to the intervention schedule.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study anticipates that TriVital Mix will demonstrate superior efficacy compared to standard saline in providing rapid relief from allergic rhinitis symptoms. It is expected to significantly reduce inflammation and prevent the development of nasal polyps over time.Timepoint: baseline, 4 weeks, and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Nasal Symptom Score (NSS) from baselineTimepoint: Baseline, 4 weeks, 8 weeks, and 12 weeks | — |
Countries
India
Contacts
saveetha medical college and hospitals